Allogene Therapeutics Inc (ALLO)
2.755
-0.10
(-3.67%)
USD |
NASDAQ |
May 10, 16:00
2.755
0.00 (0.00%)
After-Hours: 20:00
Allogene Therapeutics Price to Book Value: 0.9094 for May 10, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 09, 2024 | 0.9441 |
| May 08, 2024 | 0.9111 |
| May 07, 2024 | 0.9606 |
| May 06, 2024 | 0.9936 |
| May 03, 2024 | 1.013 |
| May 02, 2024 | 0.9804 |
| May 01, 2024 | 0.9639 |
| April 30, 2024 | 0.9111 |
| April 29, 2024 | 0.9375 |
| April 26, 2024 | 0.954 |
| April 25, 2024 | 0.9425 |
| April 24, 2024 | 1.004 |
| April 23, 2024 | 1.112 |
| April 22, 2024 | 1.122 |
| April 19, 2024 | 1.146 |
| April 18, 2024 | 1.142 |
| April 17, 2024 | 1.159 |
| April 16, 2024 | 1.155 |
| April 15, 2024 | 1.172 |
| April 12, 2024 | 1.254 |
| April 11, 2024 | 1.317 |
| April 10, 2024 | 1.344 |
| April 09, 2024 | 1.357 |
| April 08, 2024 | 1.314 |
| April 05, 2024 | 1.307 |
| Date | Value |
|---|---|
| April 04, 2024 | 1.337 |
| April 03, 2024 | 1.350 |
| April 02, 2024 | 1.344 |
| April 01, 2024 | 1.446 |
| March 28, 2024 | 1.476 |
| March 27, 2024 | 1.472 |
| March 26, 2024 | 1.390 |
| March 25, 2024 | 1.416 |
| March 22, 2024 | 1.406 |
| March 21, 2024 | 1.446 |
| March 20, 2024 | 1.462 |
| March 19, 2024 | 1.449 |
| March 18, 2024 | 1.385 |
| March 15, 2024 | 1.538 |
| March 14, 2024 | 1.484 |
| March 13, 2024 | 1.611 |
| March 12, 2024 | 1.618 |
| March 11, 2024 | 1.672 |
| March 08, 2024 | 1.732 |
| March 07, 2024 | 1.834 |
| March 06, 2024 | 1.854 |
| March 05, 2024 | 1.778 |
| March 04, 2024 | 1.798 |
| March 01, 2024 | 1.626 |
| February 29, 2024 | 1.616 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.658
Minimum
Nov 29 2023
11.17
Maximum
May 22 2020
3.127
Average
2.773
Median
Nov 15 2021
Price to Book Value Benchmarks
| Agenus Inc | -- |
| ANI Pharmaceuticals Inc | 3.312 |
| Vaxart Inc | 2.121 |
| aTyr Pharma Inc | 1.389 |
| PAVmed Inc | -- |
Price to Book Value Related Metrics
| PS Ratio | 4549.18 |
| Price | 2.755 |
| Earnings Yield | -76.95% |
| Market Cap | 465.85M |